[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
    "summary": "Health care stocks declined late Monday afternoon, with the NYSE Health Care Index easing 0.3% and t",
    "url": "https://finnhub.io/api/news?id=8ce48fdad5490789af4dffc3bcff8482599476d8b6295941cb85582791f9b5ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759780336,
      "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
      "id": 136990280,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Monday afternoon, with the NYSE Health Care Index easing 0.3% and t",
      "url": "https://finnhub.io/api/news?id=8ce48fdad5490789af4dffc3bcff8482599476d8b6295941cb85582791f9b5ce"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Sanofi, Chinese pharmaceutical companies and more in the latest Market Talks covering the sector.",
    "url": "https://finnhub.io/api/news?id=effdf7bfb16bae280edaf70adb930ee31f1acced4291a6e938932d5376b6844d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759767840,
      "headline": "Health Care Roundup: Market Talk",
      "id": 136989775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Find insight on Sanofi, Chinese pharmaceutical companies and more in the latest Market Talks covering the sector.",
      "url": "https://finnhub.io/api/news?id=effdf7bfb16bae280edaf70adb930ee31f1acced4291a6e938932d5376b6844d"
    }
  },
  {
    "ts": null,
    "headline": "Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035",
    "summary": "Emerging technologies in diagnostics and telemedicine are transforming patient management, although high costs and variable patient responses remain barriers. With growing investments in dermatological research, demand is driven by the aging population and advanced diagnostic techniques. Key market players include Sanofi, Regeneron, and Amgen.Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The \"Bullous Pemphigoid Market - A Global and Regional Analysis: Focus on Therapy Type and Region - Analysis and",
    "url": "https://finnhub.io/api/news?id=afc2140e94d256ab0401bbbf268fa5ae9f9b3695371c319e739b817210ad6572",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759758780,
      "headline": "Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035",
      "id": 136989540,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Emerging technologies in diagnostics and telemedicine are transforming patient management, although high costs and variable patient responses remain barriers. With growing investments in dermatological research, demand is driven by the aging population and advanced diagnostic techniques. Key market players include Sanofi, Regeneron, and Amgen.Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The \"Bullous Pemphigoid Market - A Global and Regional Analysis: Focus on Therapy Type and Region - Analysis and",
      "url": "https://finnhub.io/api/news?id=afc2140e94d256ab0401bbbf268fa5ae9f9b3695371c319e739b817210ad6572"
    }
  },
  {
    "ts": null,
    "headline": "My Top 5 Biotech Stocks Big Pharma Could Buy Next",
    "summary": "Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma players.",
    "url": "https://finnhub.io/api/news?id=0615cc217ad0cd350a198a8133c50199b31af463e4f96ab378a062934e7cccc8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759757340,
      "headline": "My Top 5 Biotech Stocks Big Pharma Could Buy Next",
      "id": 136988239,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1146642361/image_1146642361.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma players.",
      "url": "https://finnhub.io/api/news?id=0615cc217ad0cd350a198a8133c50199b31af463e4f96ab378a062934e7cccc8"
    }
  },
  {
    "ts": null,
    "headline": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finnhub.io/api/news?id=8298f57ecd4125fd4563bdabe6106665bfb1daf1775ec70417596c198206c656",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759755604,
      "headline": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
      "id": 136989777,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
      "url": "https://finnhub.io/api/news?id=8298f57ecd4125fd4563bdabe6106665bfb1daf1775ec70417596c198206c656"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Sees $83 Million Charge Hurting 3Q Results",
    "summary": "Regeneron Sees $83 Million Charge Hurting 3Q Results",
    "url": "https://finnhub.io/api/news?id=446962f376d4ac665e5fd572364cf2833897c5e848ec59d863b21d2bca1ba787",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759737540,
      "headline": "Regeneron Sees $83 Million Charge Hurting 3Q Results",
      "id": 137083659,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Sees $83 Million Charge Hurting 3Q Results",
      "url": "https://finnhub.io/api/news?id=446962f376d4ac665e5fd572364cf2833897c5e848ec59d863b21d2bca1ba787"
    }
  }
]